Adlai Nortye Group (ANL) is trading down at $15.04 (-0.33%), as of the latest quote. It operates in the Health Care sector.
| FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $45.7M | — | $5.00M | — |
| Operating income | −$8.65M | −$67.3M | −$72.6M | −$52.9M |
| Operating margin | −18.9% | — | −1451.0% | — |
| Net income | −$56.7M | −$58.8M | −$109.2M | −$51.9M |
| Net margin | −124.0% | — | −2184.6% | — |
| EPS (diluted) | −$2.23 | −$2.31 | −$2.52 | −$0.54 |
| Balance sheet | ||||
| Cash and equivalents | $64.1M | $42.8M | $91.5M | $60.9M |
| Total assets | — | $72.6M | $130.2M | $71.3M |
| Total liabilities | — | $313.9M | $55.1M | $45.8M |
| Shareholders' equity | −$185.4M | −$241.3M | $75.0M | $25.5M |
| Cash flow | ||||
| Operating cash flow | −$3.03M | −$43.2M | −$56.7M | −$51.8M |
| Capital expenditure | $1.02M | $1.25M | $200.0K | $170.0K |
| Free cash flow | −$4.05M | −$44.5M | −$56.9M | −$52.0M |
From Adlai Nortye Group's 20-F filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Per-share figures are per ordinary share, which is not always the share traded in the US: an ADS can stand for several, or for part of one. Filings on SEC EDGAR →
No recent news mentioning Adlai Nortye Group in our feed yet.